Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 5.


Chan, Ka Kui, Matchett, Kyle B, Coulter, Jonathan A, Yuen, Hiu-Fung, McCrudden, Cian M, Zhang, Shu-Dong, Irwin, Gareth W, Davidson, Matthew A, Ruelicke, Thomas, Schober, Sophie
et al (show 8 more authors) (2017) Erythropoietin drives breast cancer progression by activation of its receptor EPOR. ONCOTARGET, 8 (24). pp. 38251-38263.


Chan, Ka Kui, Matchett, Kyle B, McEnhill, Paul M, Dakir, El Habib, McMullin, Mary Frances, El-Tanani, Yahia, Patterson, Laurence, Faheem, Ahmed, Rudland, Philip S ORCID: 0000-0002-7491-0846, McCarron, Paul A
et al (show 1 more authors) (2015) Protein deregulation associated with breast cancer metastasis. CYTOKINE & GROWTH FACTOR REVIEWS, 26 (4). pp. 415-423.


Yuen, Hiu-Fung, Chan, Ka-Kui, Platt-Higgins, Angela, Dakir, El-Habib, Matchett, Kyle B, Haggag, Yusuf Ahmed, Jithesh, Puthen V, Habib, Tanwir, Faheem, Ahmed, Dean, Fennell A
et al (show 3 more authors) (2016) Ran GTPase promotes cancer progression via Met receptor-mediated downstream signaling. ONCOTARGET, 7 (46). pp. 75854-75864.


Yuen, Hiu-Fung, Gunasekharan, Vignesh-Kumar ORCID: 0000-0002-2471-8485, Chan, Ka-Kui, Zhang, Shu-Dong ORCID: 0000-0002-7721-0167, Platt-Higgins, Angela, Gately, Kathy ORCID: 0000-0002-9616-424X, O'Byrne, Ken ORCID: 0000-0002-6754-5633, Fennell, Dean A, Johnston, Patrick G, Rudland, Philip S ORCID: 0000-0002-7491-0846
et al (show 1 more authors) (2013) RanGTPase: a candidate for Myc-mediated cancer progression. Journal of the National Cancer Institute, 105 (7). pp. 475-488.


Dakir, El-Habib, Pickard, Adam, Srivastava, Kirtiman, McCrudden, Cian M, Gross, Stephane R ORCID: 0000-0002-0867-8866, Lloyd, Stephen, Zhang, Shu-Dong, Margariti, Andriana, Morgan, Richard, Rudland, Philip S ORCID: 0000-0002-7491-0846
et al (show 1 more authors) (2018) The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer. Oncotarget, 9 (79). pp. 34889-34910.

This list was generated on Sat Apr 13 19:54:20 2024 BST.